化学
人血清白蛋白
细胞毒性
体内
PI3K/AKT/mTOR通路
癌细胞
细胞凋亡
体外
纳米颗粒
癌症治疗
组合化学
生物化学
生物物理学
药理学
癌症
纳米技术
医学
材料科学
生物技术
内科学
生物
作者
Zhenlei Zhang,Tongfu Yang,Juzheng Zhang,Wenjuan Li,Shanhe Li,Hongbin Sun,Hong Liang,Feng Yang
标识
DOI:10.1021/acs.jmedchem.1c01790
摘要
To effectively integrate diagnosis and therapy for tumors, we proposed to develop an indium (In) agent based on the unique property of human serum albumin (HSA) nanoparticles (NPs). A novel In(III) quinoline-2-formaldehyde thiosemicarbazone compound (C5) was optimized with remarkable cytotoxicity and fluorescence to cancer cells in vitro. An HSA-C5 complex NP delivery system was then successfully constructed. Importantly, the HSA-C5 complex NPs have stronger bioimaging and therapeutic efficiency relative to C5 alone in vivo. Besides, the results of gene chip analysis revealed that C5/HSA-C5 complex NPs act on cancer cells through multiple mechanisms: inducing autophagy, apoptosis, and inhibiting the PI3K-Akt signaling pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI